The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.20
Bid: 50.40
Ask: 51.20
Change: 0.80 (1.59%)
Spread: 0.80 (1.587%)
Open: 51.00
High: 51.20
Low: 50.00
Prev. Close: 50.40
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re Pensions

7 Dec 2015 07:00

RNS Number : 1269I
Renold PLC
07 December 2015
 

Renold plc

("Renold" or "the Company" or "the Group")

 

Re: Lowering risk and reducing liabilities for pension schemes

 

Renold, a leading international supplier of industrial chains and related power transmission products, announces further actions to reduce and de-risk pension liabilities in the UK and Germany.

 

UK: Second medically underwritten insured buy-in

The Renold Pension Scheme (the Group's UK legacy Defined Benefit pension scheme, 'the RPS') has completed a second medically underwritten insured buy-in that fully de-risks another £27m (approximately 25%) of the current UK pensioner liabilities (1) and follows a similar transaction in April 2015. Both transactions were in respect of the highest risk pensioner members (2) and the transaction announced today results in approximately 50% of current UK pensioner liabilities being fully de-risked.

 

Similarly attractive pricing terms were obtained compared to the April transaction and hence the RPS was again able to secure the liabilities at a small discount to their assumed funding valuation. As a result, the transaction has improved the funding level of the RPS in addition to the further reduction in risk. The transaction is broadly neutral from an accounting valuation perspective and was structured as a 'buy-in' and hence the insurance policy remains an asset of the scheme. Consideration for the buy-in will be sourced entirely from a portion of the scheme's holding of high quality corporate bonds. The Group has agreed that a modest acceleration of up to £1.0m of contingent cash contributions that would have been payable in the financial year ending March 2018, will be made in the financial year ending March 2017.

 

The Group is now fully protected against risks arising from volatility in longevity, inflation and interest rates in respect of these members. These factors will be relevant to future triennial revaluations and funding discussions with Trustees.

 

Closure of unfunded German pension scheme to future accrual

A German court has confirmed that the pension scheme of the Group's subsidiary in Germany was properly closed to future accrual with effect from 30 September 2013. This is expected to result in a reduction in the Group's unfunded pension obligations of approximately 6.0% or £1.5m, based on market conditions and exchange rates as at 30 September 2015 and will be fully disclosed in the Group's Annual Report and Accounts for the year ending 31 March 2016. The confirmed closure also reduces annual service costs as well as eliminating the German scheme's exposure to the risk of salary inflation.

 

Robert Purcell, Chief Executive of Renold, commented:

 

"These actions significantly reduce and further de-risk our pension liabilities in the UK and Germany. At the same time, they lower future funding costs and thus protect the Group's ability to invest further in the business. They are also important milestones in rebuilding the Group's balance sheet and delivering sustainable gains in shareholder value."

 

7 December 2015

 

(1) Liabilities assessed on a scheme funding basis

(2) High liability members from a scheme perspective are those with higher annual pension incomes who represent a significant concentration of longevity risk for the scheme.

 

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Finance Director

Instinctif

020 7457 2020

Mark Garraway

Helen Tarbet

 

 

 

 

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNUWRVKAURAA
Date   Source Headline
30th Aug 20139:00 amRNSDirector/PDMR Shareholding
28th Aug 20133:27 pmRNSDirector/PDMR Shareholding
27th Aug 201310:00 amRNSStrategic Review Update
22nd Aug 20132:33 pmRNSIssue of Equity
13th Aug 20132:00 pmRNSIssue of Equity
25th Jul 20134:23 pmRNSGrant of awards
24th Jul 20131:08 pmRNSResult of AGM
23rd Jul 20137:00 amRNSAGM Statement and Interim Management Statement
8th Jul 20137:00 amRNSMerger of the UK defined benefit pensions schemes
5th Jul 20134:13 pmRNSHolding(s) in Company
4th Jul 20134:35 pmRNSPrice Monitoring Extension
1st Jul 201310:20 amRNSHolding(s) in Company
21st Jun 201312:14 pmRNSRe. Annual Report and Accounts
18th Jun 201310:21 amRNSHolding(s) in Company
17th Jun 201311:32 amRNSHolding(s) in Company
17th Jun 201310:54 amRNSDirector/PDMR Shareholding
3rd Jun 20134:35 pmRNSPrice Monitoring Extension
3rd Jun 20132:15 pmRNSDirector/PDMR Shareholding
28th May 20137:00 amRNSFinal Results
23rd May 20131:27 pmRNSHolding(s) in Company
9th May 20139:39 amRNSHolding(s) in Company
8th May 20132:27 pmRNSHolding(s) in Company
2nd May 20135:47 pmRNSNotification of major interest in shares
2nd May 20134:40 pmRNSSecond Price Monitoring Extn
2nd May 20134:35 pmRNSPrice Monitoring Extension
1st May 20134:40 pmRNSSecond Price Monitoring Extn
1st May 20134:35 pmRNSPrice Monitoring Extension
1st May 20137:00 amRNSTrading Update
10th Apr 20134:35 pmRNSPrice Monitoring Extension
28th Mar 20135:09 pmRNSDirector/PDMR Shareholding
26th Mar 20132:45 pmRNSRe: Pensions Scheme
27th Feb 20137:00 amRNSDirector/PDMR Shareholding
14th Feb 20137:00 amRNSInterim Management Statement
30th Jan 201311:02 amRNSDirector/PDMR Shareholding
21st Jan 20135:08 pmRNSDirector/PDMR Shareholding
21st Jan 201312:31 pmRNSDirectorate Matters
31st Dec 201212:40 pmRNSSecond Price Monitoring Extn
31st Dec 201212:35 pmRNSPrice Monitoring Extension
21st Dec 20127:00 amRNSRe. Directorate Appointment
19th Dec 20124:41 pmRNSSecond Price Monitoring Extn
19th Dec 20124:35 pmRNSPrice Monitoring Extension
10th Dec 20124:40 pmRNSSecond Price Monitoring Extn
10th Dec 20124:35 pmRNSPrice Monitoring Extension
3rd Dec 20122:14 pmRNSHolding(s) in Company
28th Nov 20127:00 amRNSDirector/PDMR Shareholding
26th Nov 20121:47 pmRNSNotification of major interest in shares
26th Nov 20121:03 pmRNSDirector/PDMR Shareholding
20th Nov 20127:00 amRNSHalf Yearly Report
12th Nov 20124:40 pmRNSSecond Price Monitoring Extn
12th Nov 20124:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.